Paper40201546
Targeting neuroplasticity: a viewpoint on a future research direction with Parkinson's disease-related fatigue.
Hao S and 1 other. Front Aging Neurosci, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Targeting neuroplasticity: a viewpoint on a future research direction with Parkinson's disease-related fatigue. Papers, record 40201546. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40201546
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting neuroplasticity: a viewpoint on a future research direction with Parkinson's disease-related fatigue.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References91
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37287291 | Brain-Derived Neurotrophic Factor - The Protective Agent Against Neurological Disorders. | CNS Neurol Disord Drug Targets | 2024 | https://conductscience.org/library/papers/37287291 | PubMed |
| 2 | 8413960 | Fatigue in Parkinson's disease. | Neurology | 1993 | https://conductscience.org/library/papers/8413960 | PubMed |
| 3 | 34789147 | Brain is modulated by neuronal plasticity during postnatal development. | J Physiol Sci | 2021 | https://conductscience.org/library/papers/34789147 | PubMed |
| 4 | 35743271 | Recent Advances on the Role of Brain-Derived Neurotrophic Factor (BDNF) in Neurodegenerative Diseases. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35743271 | PubMed |
| 5 | 32397504 | The Role of BDNF on Aging-Modulation Markers. | Brain Sci | 2020 | https://conductscience.org/library/papers/32397504 | PubMed |
| 6 | 38540162 | Some Novel Therapies in Parkinson's Disease: A Promising Path Forward or Not Yet? A Systematic Review of the Literature. | Biomedicines | 2024 | https://conductscience.org/library/papers/38540162 | PubMed |
| 7 | 32920893 | Progression of fatigue in Parkinson's disease - a 9-year follow-up. | Eur J Neurol | 2021 | https://conductscience.org/library/papers/32920893 | PubMed |
| 8 | 27175281 | Clinical characteristics of fatigued Parkinson's patients and the response to dopaminergic treatment. | Transl Neurodegener | 2016 | https://conductscience.org/library/papers/27175281 | PubMed |
| 9 | 34703037 | Glial Cells as Possible Targets of Neuroprotection through Neurotrophic and Antioxidative Molecules in the Central and Enteric Nervous Systems in Parkinson's Disease. | Acta Med Okayama | 2021 | https://conductscience.org/library/papers/34703037 | PubMed |
| 10 | 37450039 | BDNF alleviates Parkinson's disease by promoting STAT3 phosphorylation and regulating neuronal autophagy. | Cell Tissue Res | 2023 | https://conductscience.org/library/papers/37450039 | PubMed |
| 11 | 27239558 | Fatigue in Parkinson's disease: report from a mutidisciplinary symposium. | NPJ Parkinsons Dis | 2016 | https://conductscience.org/library/papers/27239558 | PubMed |
| 12 | 39654952 | Exploring the layers of fatigue in Parkinson's Disease: A comprehensive analysis of its prevalence and contributing factors. | Clin Park Relat Disord | 2024 | https://conductscience.org/library/papers/39654952 | PubMed |
| 13 | 31583594 | Microglia in Parkinson's Disease. | Adv Exp Med Biol | 2019 | https://conductscience.org/library/papers/31583594 | PubMed |
| 14 | 35005068 | Demographic Influences on the Relationship Between Fatigue and Quality of Life in Parkinson's Disease. | Mov Disord Clin Pract | 2022 | https://conductscience.org/library/papers/35005068 | PubMed |
| 15 | 33434621 | ERRγ ligand HPB2 upregulates BDNF-TrkB and enhances dopaminergic neuronal phenotype. | Pharmacol Res | 2021 | https://conductscience.org/library/papers/33434621 | PubMed |
| 16 | 34724287 | Effects of exergaming on hippocampal volume and brain-derived neurotrophic factor levels in Parkinson's disease. | Eur J Neurol | 2022 | https://conductscience.org/library/papers/34724287 | PubMed |
| 17 | 32415886 | Neuroglial transmitophagy and Parkinson's disease. | Glia | 2020 | https://conductscience.org/library/papers/32415886 | PubMed |
| 18 | 39200225 | BDNF-Regulated Modulation of Striatal Circuits and Implications for Parkinson's Disease and Dystonia. | Biomedicines | 2024 | https://conductscience.org/library/papers/39200225 | PubMed |
| 19 | 38244460 | Tai Chi improves non-motor symptoms of Parkinson's disease: One-year randomized controlled study with the investigation of mechanisms. | Parkinsonism Relat Disord | 2024 | https://conductscience.org/library/papers/38244460 | PubMed |
| 20 | 11455047 | Fatigue in patients with Parkinson's disease. | Behav Neurol | 2000 | https://conductscience.org/library/papers/11455047 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40201546
GET https://conductscience.org/api/papers/v1/40201546/references?page=2